AEON Biopharma Inc. (AEON)

NASDAQ: AEON · Real-Time Price · USD

0.49

0.05 (12.13%)

At close: May 02, 2025, 3:58 PM

0.52

5.91%

After-hours: May 02, 2025, 05:56 PM EDT

AEON Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q2 2023	Q1 2023	Q4 2022
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Net Income	2.08M	-6.17M	164.11M	-118.02M	-15.38M	-17.64M	-34.56M
Depreciation & Amortization	23K	25K	24K	25K	23K	25K	32K
Stock-Based Compensation	1.34M	1.59M	1.69M	1.62M	1.15M	1.36M	1.67M
Other Working Capital	2.02M	-2.18M	1.39M	64K	-57K	40K	-445K
Other Non-Cash Items	-7.36M	2.17M	-171.84M	63.86M	1.45M	4.66M	19.67M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	3.29M	-577K	-2.11M	96K	2.67M	539K	4.74M
Operating Cash Flow	-621K	-2.96M	-8.12M	-8.6M	-10.09M	-11.06M	-8.45M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a	n/a	-9K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a	n/a	-9K
Debt Repayment	n/a	n/a	10M	5M	8M	6M	-3.99M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	50K	n/a	n/a	n/a	n/a	n/a
Financial Cash Flow	97K	50K	10M	5M	8M	6M	-3.99M
Net Cash Flow	-524K	-2.9M	1.88M	-3.6M	-2.08M	-5.06M	-12.46M
Free Cash Flow	-621K	-2.96M	-8.12M	-8.6M	-10.09M	-11.06M	-8.46M